81
ECP 2014 ·
London
Poster Presentations
a
Sunday
Sunday, 31 Aug
PS-03
063
Expression of Epithelial-Mesenchymal
Transition (EMT) markers in phyllodes
breast tumours: An immunohistochemi-
cal study
Ioanna Akrida,
Greece
V. Bravou, I. Lilis, V. Zolota, S. Kounelis,
H. Papadaki
064
Is mammaglobin expression in breast can-
cer associated with angiogenesis, lym-
phangiogenesis or cell proliferation?
Naomi Whiteoak,
United Kingdom
L. Baker, L. Hall
065
CD10 immunohistochemical expression in
apocrine lesions of the breast
Bence Kõvári,
Hungary
G. Cserni
066
Growth Hormone Releasing Hormone
Receptor (GHRH-R) expression in various
types of apocrine epithelial lesions: Apo-
crine breast carcinomas and cutaneous
tumours with apocrine features
Bence Kõvári,
Hungary
S. Vranic, L. Kocsis, A. Sapino, G. Cserni
067
Expression of Calpain-9 is associated with
survival following hormone therapy in
breast cancer
Jillian Davis,
United Kingdom
S. Martin, P. Patel, A. Green, E. Rakha,
I. Ellis, S. Storr
068
Microvascular proliferation in breast can-
cer subtypes
Maria Ryssdal Kraby,
Norway
S. Opdahl, K. Krüger, B. Ytterhus,
L. J. Vatten, L. A. Akslen, A. M. Bofin
069
Invasive lobular breast cancer: Impact of
histopathological grade and immunohisto-
chemical markers
Monica J. Engstrøm,
Norway
S. Opdahl, L. J. Vatten, O. A. Haugen,
A. M. Bofin
070
Molecular subtypes, histopathological
grade and survival in a historic cohort of
breast cancer patients
Monica Engstrøm,
Norway
S. Opdahl, A. I. Hagen, P. R. Romundstad,
L. A. Akslen, O. A. Haugen, L. J. Vatten,
A. M. Bofin
071
TOP2A gene copy number change in breast
cancer
Monica Engstrøm,
Norway
B. Ytterhus, L. J. Vatten, S. Opdahl,
A. M. Bofin
072
Is it invasive carcinoma developing inside
the fibroadenoma or fibroadenoma which
has been infiltrated by invasive carcinoma?
Ebru Demiralay,
Turkey
S. Yildiz, A. Demirag
073
The proliferation marker Ki67 in breast
cancer: A reliability study to assess its
readiness for routine clinical management
Abir A. Abdelhadi Muftah,
United Kingdom
M. Al-Kaabi, M. Aleskandarany, D. Jerjees,
N. Alsubhi, R. Abduljabbar, C. Nolan,
A. Green, I. Ellis, E. Rakha
074
Checkpoint Kinase1 (CHK1) is an important
biomarker in breast cancer related to DNA-
damage repair mechanism and response to
chemotherapy
Methaq Al-Kaabi,
United Kingdom
A. Alashareeda, D. Jerjees, A. A. Abdelhadi
Muftah, N. Alsubhi, A. Green, S. Chan,
E. Cornford, S. Madhusudan, I. Ellis,
E. Rakha
075
Does single receptor positive breast carci-
noma differ with regard to age, tumour
grade and HER2 amplification status?
Alp Özgüzer,
Turkey
U. Bayol, E. E. Pala, C. Akdeniz
077
Does loss of C-KIT protein in benign and
non-invasive apocrine lesions indicate
potential for malignant transformation?
Trine Tramm,
Denmark
J.-Y. Kim, S. Leibl, F. Moinfar, F. Tavassoli
